Cover Image
Market Research Report

Europe Cell-based Assays Market: Industry Trends and Forecast to 2026

Published by Data Bridge Market Research Private Limited Product code 913487
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Cell-based Assays Market: Industry Trends and Forecast to 2026
Published: October 1, 2019 Content info: 120 Pages
Description

Europe cell based assays market is projected to register a substantial CAGR in the forecast period of 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Type (Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay, Others), Product & Services (Consumables, Services, Instruments and Software), Technology (Flow Cytometry, High Throughput Screening, High Content Screening, Label Free Detection), Application (Drug Discovery, Basic Research, Others), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions, Government Organizations, Others), Distribution Channel (Direct, Indirect), Country (Germany, France, United Kingdom, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe)

Some of the major factors contributing to the growth of the market:

  • Rising demands for novel small molecules, bio-therapeutic and cell based therapies
  • Increasing life sciences R&D expenditure in Europe
  • Increasing incidence of gene mutation and tumor disease in Europe

Key Market Players:

The key market players for Europe cell based assays market are listed below:

  • GENERAL ELECTRIC
  • Danaher
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Bio-Rad Laboratories, Inc.
  • ATCC
  • Aurelia Bioscience Ltd
  • BD
  • BioAgilytix Labs
  • BioVision Inc.
  • Cell Signaling Technology, Inc
  • Cisbio
  • Enzo Biochem Inc
  • Eurofins Scientific
  • LakePharma, Inc
  • Lonza
  • Miltenyi Biotec
  • XenoDiagnostics, LLC
Table of Contents

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. OVERVIEW OF EUROPE CELL BASED ASSAYS MARKET
  • 1.4. LIMITATIONS
  • 1.5. MARKETS COVERED

2. MARKET SEGMENTATION

  • 2.1. MARKETS COVERED
  • 2.2. EUROPE CELL BASED ASSAYS MARKET: GEOGRAPHICAL SCOPE
  • 2.3. YEARS CONSIDERED FOR THE STUDY
  • 2.4. CURRENCY AND PRICING
  • 2.5. DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7. DBMR MARKET POSITION GRID (ON THE BASIS OF PRODUCTS)
  • 2.8. DBMR MARKET POSITION GRID
  • 2.9. DBMR VENDOR SHARE ANALYSIS
  • 2.10. MULTIVARIATE MODELING
  • 2.11. PRODUCTS LIFELINE CURVE
  • 2.12. SECONDARY SOURCES
  • 2.13. ASSUMPTIONS

3. MARKET OVERVIEW

  • 3.1. DRIVERS
    • 3.1.1. INCREASING INCIDENCE OF CHRONIC DISEASES
    • 3.1.2. RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES
    • 3.1.3. INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURE
  • 3.2. RESTRAINT
    • 3.2.1. STRINGENT REGULATORY REQUIREMENTS
    • 3.2.2. HIGH COST OF INSTRUMENTATION
  • 3.3. OPPORTUNITIES
    • 3.3.1. TECHNOLOGICAL ADVANCEMENTS
    • 3.3.2. STRATEGIC INITIATIVE BY THE MARKET PLAYERS
  • 3.4. CHALLENGES
    • 3.4.1. CHALLENGING ANALYSIS PROCEDURE

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. EUROPE CELL-BASED ASSAYS MARKET, BY TYPE

  • 6.1. OVERVIEW
  • 6.2. CELL VIABILITY ASSAY
  • 6.3. CYTOTOXICITY ASSAY
  • 6.4. CELL PROLIFERATION ASSAY
  • 6.5. CELL DEATH ASSAY
  • 6.6. OTHERS

7. EUROPE CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICES

  • 7.1. OVERVIEW
  • 7.2. CONSUMABLES
    • 7.2.1. ASSAY KITS
    • 7.2.2. CELL LINES
      • 7.2.2.1. PRIMARY CELL LINES
      • 7.2.2.2. STEM CELL LINES
      • 7.2.2.3. IMMORTALIZED CELL LINES
    • 7.2.3. REAGENTS
    • 7.2.4. MICROPLATES
  • 7.3. SERVICES
  • 7.4. INSTRUMENTS AND SOFTWARE

8. EUROPE CELL-BASED ASSAYS MARKET, BY TECHNOLOGY

  • 8.1. OVERVIEW
  • 8.2. HIGH THROUGHPUT SCREENING
  • 8.3. FLOW CYTOMETRY
  • 8.4. HIGH CONTENT SCREENING
  • 8.5. LABEL FREE DETECTION

9. EUROPE CELL-BASED ASSAYS MARKET, BY APPLICATION

  • 9.1. OVERVIEW
  • 9.2. DRUG DISCOVERY
    • 9.2.1. PREDICTIVE TOXICOLOGY
    • 9.2.2. PHARMACODYNAMIC STUDIES
    • 9.2.3. ADME RESEARCH
  • 9.3. BASIC RESEARCH
  • 9.4. OTHERS

10. EUROPE CELL-BASED ASSAYS MARKET, BY END USER

  • 10.1. OVERVIEW
  • 10.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.3. CONTRACT RESEARCH ORGANIZATIONS
  • 10.4. ACADEMIC & RESEARCH INSTITUTIONS
  • 10.5. GOVERNMENT ORGANIZATIONS
  • 10.6. OTHERS

11. EUROPE CELL-BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL

  • 11.1. OVERVIEW
  • 11.2. DIRECT
  • 11.3. INDIRECT

12. EUROPE CELL BASED ASSAY MARKET, BY GEOGRAPHY

  • 12.1. EUROPE
    • 12.1.1. GERMANY
    • 12.1.2. FRANCE
    • 12.1.3. UNITED KINGDOM
    • 12.1.4. ITALY
    • 12.1.5. SPAIN
    • 12.1.6. RUSSIA
    • 12.1.7. NETHERLANDS
    • 12.1.8. SWITZERLAND
    • 12.1.9. BEGIUM
    • 12.1.10. TURKEY
    • 12.1.11. REST OF EUROPE

13. EUROPE CELL BASED ASSAYS MARKET FOR PRODUCTS, COMPANY LANDSCAPE

  • 13.1. COMPANY SHARE ANALYSIS: EUROPE

14. EUROPE CELL BASED ASSAYS MARKET FOR SERVICES, COMPANY LANDSCAPE

  • 14.1. COMPANY SHARE ANALYSIS: EUROPE

15. COMPANY PROFILE

  • 15.1. GENERAL ELECTRIC
    • 15.1.1. COMPANY SNAPSHOT
    • 15.1.2. REVENUE ANALYSIS
    • 15.1.3. COMPANY SHARE ANALYSIS
    • 15.1.4. PRODUCT PORTFOLIO
    • 15.1.5. RECENT DEVELOPMENTS
  • 15.2. DANAHER
    • 15.2.1. COMPANY SNAPSHOT
    • 15.2.2. REVENUE ANALYSIS
    • 15.2.3. COMPANY SHARE ANALYSIS
    • 15.2.4. PRODUCT PORTFOLIO
    • 15.2.5. RECENT DEVELOPMENT
  • 15.3. AGILENT TECHNOLOGIES, INC.
      • 15.3.1.1. COMPANY SNAPSHOT
    • 15.3.2. REVENUE ANALYSIS
    • 15.3.3. COMPANY SHARE ANALYSIS
    • 15.3.4. PRODUCT PORTFOLIO
    • 15.3.5. RECENT DEVELOPMENTS
  • 15.4. THERMO FISHER SCIENTIFIC INC
    • 15.4.1. COMPANY SNAPSHOT
    • 15.4.2. REVENUE ANALYSIS
    • 15.4.3. COMPANY SHARE ANALYSIS
    • 15.4.4. PRODUCT PORTFOLIO
    • 15.4.5. RECENT DEVELOPMENT
  • 15.5. MERCK KGAA
    • 15.5.1. COMPANY SNAPSHOT
    • 15.5.2. REVENUE ANALYSIS
    • 15.5.3. PRODUCT PORTFOLIO
    • 15.5.4. RECENT DEVELOPMENT
  • 15.6. PERKINELMER INC, INC.
    • 15.6.1. COMPANY SNAPSHOT
    • 15.6.2. REVENUE ANALYSIS
    • 15.6.3. PRODUCT PORTFOLIO
    • 15.6.4. RECENT DEVELOPMENT
  • 15.7. BIO-RAD LABORATORIES, INC.
    • 15.7.1. COMPANY SNAPSHOT
    • 15.7.2. REVENUE ANALYSIS
    • 15.7.3. PRODUCT PORTFOLIO
    • 15.7.4. RECENT DEVELOPMENTS
  • 15.8. ATCC
    • 15.8.1. COMPANY SNAPSHOT
    • 15.8.2. PRODUCT PORTFOLIO
    • 15.8.3. RECENT DEVELOPMENT

  • 15.9. AURELIA BIOSCIENCE LTD.
    • 15.9.1. COMPANY SNAPSHOT
    • 15.9.2. SERVICE PORTFOLIO
    • 15.9.3. RECENT DEVELOPMENT
  • 15.10. BD
    • 15.10.1. COMPANY SNAPSHOT
    • 15.10.2. REVENUE ANALYSIS
    • 15.10.3. PRODUCT PORTFOLIO
    • 15.10.4. RECENT DEVELOPMENTS
  • 15.11. BIOAGILYTIX LABS
    • 15.11.1. COMPANY SNAPSHOT
    • 15.11.2. SERVICE PORTFOLIO
    • 15.11.3. RECENT DEVELOPMENTS
  • 15.12. BIOVISION INC.
    • 15.12.1. COMPANY SNAPSHOT
    • 15.12.2. PRODUCT PORTFOLIO
    • 15.12.3. RECENT DEVELOPMENT
  • 15.13. CELL SIGNALING TECHNOLOGY, INC.
    • 15.13.1. COMPANY SNAPSHOT
    • 15.13.2. PRODUCT PORTFOLIO
    • 15.13.3. RECENT DEVELOPMENT
  • 15.14. CISBIO
    • 15.14.1. COMPANY SNAPSHOT
    • 15.14.2. PRODUCT PORTFOLIO
    • 15.14.3. RECENT DEVELOPMENT
  • 15.15. ENZO BIOCHEM INC.
    • 15.15.1. COMPANY SNAPSHOT
    • 15.15.2. REVENUE ANALYSIS
    • 15.15.3. PRODUCT PORTFOLIO
    • 15.15.4. RECENT DEVELOPMENT
  • 15.16. EUROFINS SCIENTIFIC
    • 15.16.1. COMPANY SNAPSHOT
    • 15.16.2. REVENUE ANALYSIS
    • 15.16.3. PRODUCT AND SERVICE PORTFOLIO
    • 15.16.4. RECENT DEVELOPMENTS
  • 15.17. LAKEPHARMA, INC.
    • 15.17.1. COMPANY SNAPSHOT
    • 15.17.2. SERVICE PORTFOLIO
    • 15.17.3. RECENT DEVELOPMENT

  • 15.18. LONZA
    • 15.18.1. COMPANY SNAPSHOT
    • 15.18.2. REVENUE ANALYSIS
    • 15.18.3. SERVICE PORTFOLIO
    • 15.18.4. RECENT DEVELOPMENT
  • 15.19. MILTENYI BIOTEC
    • 15.19.1. COMPANY SNAPSHOT
      • 15.19.2.2. PRODUCT PORTFOLIO
    • 15.19.3. RECENT DEVELOPMENT
  • 15.20. XENO DIAGNOSTICS, LLC.
    • 15.20.1. COMPANY SNAPSHOT
    • 15.20.2. PRODUCT PORTFOLIO
    • 15.20.3. RECENT DEVELOPMENT

16. QUESTIONNAIRE

17. RELATED REPORTS

LIST OF TABLES

  • TABLE 1 AGEING WORLD POPULATION (IN MILLIONS)
  • TABLE 2 TABLE REGIONS BY DIABETES PREVALENCE (%) IN ELDERLY POPULATION IN 2017 AND 2045 (IN MILLIONS)
  • TABLE 3 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE
  • TABLE 4 EUROPE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 5 EUROPE CELL VIABILITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 6 EUROPE CYTOTOXICITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 7 EUROPE CELL PROLIFERATION ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 EUROPE CELL DEATH ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 9 EUROPE OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 EUROPE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 11 EUROPE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 EUROPE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 13 EUROPE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 14 EUROPE SERVICES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 EUROPE INSTRUMENTS AND SOFTWARE IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 EUROPE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 17 EUROPE HIGH THROUGHPUT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18 EUROPE FLOW CYTOMETRY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19 EUROPE HIGH CONTENT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 20 EUROPE LABEL FREE DETECTION IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 21 EUROPE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 22 EUROPE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 23 EUROPE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 24 EUROPE BASIC RESEARCH IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 25 EUROPE OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26 EUROPE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 27 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 28 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 29 EUROPE ACADEMIC & RESEARCH INSTITUTIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 30 EUROPE GOVERNMENT ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 31 EUROPE OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 32 EUROPE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 33 EUROPE DIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 34 EUROPE INDIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 35 EUROPE CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 36 EUROPE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 37 EUROPE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 38 EUROPE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 39 EUROPE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 40 EUROPE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 41 EUROPE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 42 EUROPE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 43 EUROPE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 44 EUROPE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 45 GERMANY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 46 GERMANY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 47 GERMANY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 48 GERMANY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 49 GERMANY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 50 GERMANY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 51 GERMANY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 52 GERMANY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 53 FRANCE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 54 FRANCE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 55 FRANCE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 56 FRANCE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 57 FRANCE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 58 FRANCE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 59 FRANCE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 60 FRANCE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 61 FRANCE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 62 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 63 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 64 UNITED KINGDOM CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 65 UNITED KINGDOM CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 66 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 67 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 68 UNITED KINGDOM DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 69 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 70 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 71 ITALY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 72 ITALY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 73 ITALY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 74 ITALY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 75 ITALY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 76 ITALY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 77 ITALY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 78 ITALY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 79 ITALY CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 80 SPAIN CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 81 SPAIN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 82 SPAIN CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 83 SPAIN CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 84 SPAIN CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 85 SPAIN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 86 SPAIN DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 87 SPAIN CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 88 SPAIN CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 89 RUSSIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 90 RUSSIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 91 RUSSIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 92 RUSSIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 93 RUSSIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 94 RUSSIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 95 RUSSIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 96 RUSSIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 97 RUSSIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 98 NETHERLANDS CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 99 NETHERLANDS CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 100 NETHERLANDS CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 101 NETHERLANDS CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 102 NETHERLANDS CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 103 NETHERLANDS CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 104 NETHERLANDS DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 105 NETHERLANDS CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 106 NETHERLANDS CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 107 SWITZERLAND CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 108 SWITZERLAND CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 109 SWITZERLAND CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 110 SWITZERLAND CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 111 SWITZERLAND CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 112 SWITZERLAND CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 113 SWITZERLAND DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 114 SWITZERLAND CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 115 SWITZERLAND CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 116 BELGIUM CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 117 BELGIUM CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 118 BELGIUM CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 119 BELGIUM CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 120 BELGIUM CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 121 BELGIUM CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 122 BELGIUM DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 123 BELGIUM CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 124 BELGIUM CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 125 TURKEY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 126 TURKEY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 127 TURKEY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 128 TURKEY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 129 TURKEY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 130 TURKEY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 131 TURKEY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 132 TURKEY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 133 TURKEY CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 134 REST OF EUROPE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 EUROPE CELL BASED ASSAYS MARKET
  • FIGURE 2 EUROPE CELL BASED ASSAYS MARKET: DATA VALIDATION MODEL
  • FIGURE 3 EUROPE CELL BASED ASSAYS MARKET: DROC ANALYSIS
  • FIGURE 4 EUROPE CELL BASED ASSAYS MARKET: EUROPE VS REGIONAL ANALYSIS
  • FIGURE 5 EUROPE CELL BASED ASSAYS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 EUROPE CELL BASED ASSAYS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 EUROPE CELL BASED ASSAYS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 EUROPE CELL BASED ASSAYS MARKET: DBMR MARKET POSITION GRID (ON THE BASIS OF SERVICES)
  • FIGURE 9 EUROPE CELL BASED ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS (ON THE BASIS OF PRODUCTS)
  • FIGURE 10 EUROPE CELL BASED ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS (ON THE BASIS OF SERVICES)
  • FIGURE 11 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF THE EUROPE CELL BASED ASSAYS MARKET
  • FIGURE 12 WORLDWIDE BIOPHARMA COMPANIES R&D EXPENDITURE (IN MILLION U.S. DOLLARS)
  • FIGURE 13 EUROPE CELL BASED ASSAYS MARKET: SEGMENTATION
  • FIGURE 14 INCREASING INCIDENCE OF CHRONIC DISEASES AND RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES ARE EXPECTED TO DRIVE THE EUROPE CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 15 CELL VIABILITY ASSAY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 16 EUROPE CELL BASED ASSAYS MARKET DOMINATED BY CELL VIABILITY ASSAY (2018)
  • FIGURE 17 EUROPE CELL BASED ASSAYS MARKET: BY TYPE, 2018
  • FIGURE 18 EUROPE CELL BASED ASSAYS MARKET: BY TYPE, CAGR (2019-2026)
  • FIGURE 19 EUROPE CELL BASED ASSAYS MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 20 EUROPE CELL BASED ASSAYS MARKET DOMINATED BY CONSUMABLES (2018)
  • FIGURE 21 EUROPE CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, 2018
  • FIGURE 22 EUROPE CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, CAGR (2019-2026)
  • FIGURE 23 EUROPE CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
  • FIGURE 24 EUROPE CELL BASED ASSAYS MARKET DOMINATED BY HIGH THROUGHPUT SCREENING (2018)
  • FIGURE 25 EUROPE CELL BASED ASSAYS MARKET: BY TECHNOLOGY, 2018
  • FIGURE 26 EUROPE CELL BASED ASSAYS MARKET: BY TECHNOLOGY, CAGR (2019-2026)
  • FIGURE 27 EUROPE CELL BASED ASSAYS MARKET: BY TECHNOLOGY, LIFELINE CURVE
  • FIGURE 28 EUROPE CELL BASED ASSAYS MARKET DOMINATED BY DRUG DISCOVERY (2018)
  • FIGURE 29 EUROPE CELL BASED ASSAYS MARKET: BY APPLICATION, 2018
  • FIGURE 30 EUROPE CELL BASED ASSAYS MARKET: BY APPLICATION, CAGR (2019-2026)
  • FIGURE 31 EUROPE CELL BASED ASSAYS MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 32 EUROPE CELL BASED ASSAYS MARKET DOMINATED BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (2018)
  • FIGURE 33 EUROPE CELL BASED ASSAYS MARKET: BY END USER, 2018
  • FIGURE 34 EUROPE CELL BASED ASSAYS MARKET: BY END USER, CAGR (2019-2026)
  • FIGURE 35 EUROPE CELL BASED ASSAYS MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 36 EUROPE CELL BASED ASSAYS MARKET DOMINATED BY DIRECT (2018)
  • FIGURE 37 EUROPE CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, 2018
  • FIGURE 38 EUROPE CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2019-2026)
  • FIGURE 39 EUROPE CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 40 EUROPE CELL BASED ASSAY MARKET: SNAPSHOT (2018)
  • FIGURE 41 EUROPE CELL BASED ASSAY MARKET: BY COUNTRY (2018)
  • FIGURE 42 EUROPE CELL BASED ASSAY MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 43 EUROPE CELL BASED ASSAY MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 44 EUROPE CELL BASED ASSAY MARKET: BY TYPE (2019-2026)
  • FIGURE 45 EUROPE CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 46 EUROPE CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
Back to Top